Ethical and Legal Considerations of Assisted Reproductive Technologies

---

LIVEDHPAMAWebinar

Saturday, October 22, 2022, 4:00 PM - 7:30 PM, Online (via Zoom)

There has been significant investment in women’s health services in Qatar. New major hospitals have opened boasting state of the art facilities. The Women’s Wellness and Research Center (WWRC) at Hamad Medical Corporation (HMC) and Sidra Medicine provide care to tens of thousands of women every year alongside a number of other hospitals and clinics. While women have access to the major assisted reproductive techniques (ART) in Qatar such as IVF, ICSI, PGT, IUI and others, the country lacks an overarching legislative framework for their use, and ethical examinations concerning their use are deficient. Discussions are needed on whether legislation is needed in Qatar for the use of such technologies and, if so, what form those laws should take. There are important questions about how the law can align with international best practices while being adapted to local cultural, religious and ethical expectations. Detailed discussions between experts in the field can help to illuminate the path forward.

1. 1- Examine international best practices concerning the use of ART in clinical practice.
2. 2- Appraise advances in male infertility and the associated ethical concerns.
3. 3- Discuss the current legal and religious approaches governing the use of reproductive technologies in the Arabian Gulf.
4. 4- Identify whether legislation is required in Qatar to govern the use of reproductive technology by clinicians.
5. 5- Outline the core legislative components required for ART in Qatar and how they may affect practice.

In recognition of the challenges of the Post-Covid pandemic, the division of CPD of WCM-Q would like to support the Continuing Professional Development of our Health Care Practitioner community by waiving the fees for this event.

The registration closes ONE day before the activity. You will receive a UNIQUE join link on the day of the presentation.

DHP 

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Ministry of Public Health's Department of Healthcare Professions.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 3.25 hours.

ACCME

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Weill Cornell Medicine-Qatar and Hamad Bin Khalifa University.

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to Ministry of Public Health's Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Course Directors: Thurayya Arayssi, MD, Barry Solaiman, PhD, have no relevant financial relationship to disclose and will not be discussing unlabeled/unapproved use of drugs or products.

Scientific Planning Committee: Thurayya Arayssi, MD, Barry Solaiman, PhD, Deema Al-Sheikhly, MRes, MEHP, Phyllis Navti, Doctorate in Pharmacy Practice, Mark Santos, RN, Angela Lwanga, LCSW, Hassan Ahmed, BDS, have no relevant financial relationship to disclose and will not be discussing unlabeled/unapproved use of drugs or products.

Course Faculty: Thurayya Arayssi, MD, Barry Solaiman, PhD, Mohammed Ghaly, PhD, Johnny Awwad, MD, Ahmad Majzoub, MD, have no relevant financial relationship to disclose and will not be discussing unlabeled/unapproved use of drugs or products. 

Sonia Suter, JD, has disclosed the following relationships: Speakers Bureau - Profs and Pints; Royalties or Patent Beneficiary - West Academic Publishing. The financial relationships are not relevant; WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

 Administrative Contact: Safia Rabia has no relevant financial relationship to disclose and will not be discussing unlabeled/unapproved use of drugs or products.

ICR: Barry Solaiman, PhD, has no relevant financial relationship to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

The registration form for this activity is currently unavailable.

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, October 22, 2022